Labanté Outcha Daré
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Labanté Outcha Daré has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Benoît Marin
Université de Limoges
5 shared publicationsDaniel Gérard
Sanofi
5 shared publicationsFarid Boumédiène
Université de Limoges
5 shared publicationsPierre-Emile Bruand
Sanofi
5 shared publicationsPierre-Marie Preux
Université de Limoges
5 shared publicationsValérie Lameyre
Sanofi
5 shared publications
Latest Publications
- Open Access
- 5 June 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Enhancing employee experience and workplace well-being in oncology: a bottom-up co-construction approach in healthcare institutions in Québec
Background: The commitment of health personnel in initiatives for improving their working conditions is recognised as a key condition for the success and the sustainability of such initiatives. Healthcare organisations are faced with the challenge of deploying strategies needed to mobilise this commitment. The objective of this article is to present the results of a qualitative evaluation of a bottom-up co-construction project aimed at engaging oncology staff in four Québec healthcare organisations in a process of transformation and improvement of their working environment. Methods: As part of our constructivist approach, we utilised a qualitative method, which involved conducting one-on-one interviews and gathering documentary data, including survey results, to assess the development and implementation of an intervention across four oncology units. We conducted one-on-one interviews from January 26, 2023 to March 5, 2023 with 17 workers from different categories. We collected documentary data that cover the pre-implementation activities, the co-construction workshops, and the intervention implementation. All collected data were coded and analysed using QDA Miner 6.0, and our findings were validated iteratively throughout the project, involving regular interaction with participants. Results: Fourteen areas of vulnerability emerged across the four dimensions studied, and six were targeted by workers as priorities: emotional exhaustion; role conflict; ability to learn; leadership; team cohesion; and communication. Interventions developed to address the prioritised areas included: co-development workshops; training sessions aimed at enhancing workers’ control over their working environment; team connectivity through professional and social activities; staffing and workload reviews; support from a psychosocial professional; and coaching. According to workers, most improvements occurred in two targeted areas, team cohesion and communication, even in the units where these issues were not prioritised at first. Participants pinpointed some factors that facilitated the implementation of the intervention and its impact (engagement, organisational support, the bottom-up approach) and others that created constraints (staff shortages, conflicting priorities, level of commitment). Conclusions: This exploratory work offers insightful perspectives on how a bottom-up co-construction approach can serve as a lever to engage workers to improve their work experience. It may inspire other healthcare organisations, both in oncology and in other fields of activity.
- 5 June 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Open AccessEnhancing employee experience and workplace well-being in oncology: a bottom-up co-construction approach in healthcare institutions in Québec
Background: The commitment of health personnel in initiatives for improving their working conditions is recognised as a key condition for the success and the sustainability of such initiatives. Healthcare organisations are faced with the challenge of deploying strategies needed to mobilise this commitment. The objective of this article is to present the results of a qualitative evaluation of a bottom-up co-construction project aimed at engaging oncology staff in four Québec healthcare organisations in a process of transformation and improvement of their working environment. Methods: As part of our constructivist approach, we utilised a qualitative method, which involved conducting one-on-one interviews and gathering documentary data, including survey results, to assess the development and implementation of an intervention across four oncology units. We conducted one-on-one interviews from January 26, 2023 to March 5, 2023 with 17 workers from different categories. We collected documentary data that cover the pre-implementation activities, the co-construction workshops, and the intervention implementation. All collected data were coded and analysed using QDA Miner 6.0, and our findings were validated iteratively throughout the project, involving regular interaction with participants. Results: Fourteen areas of vulnerability emerged across the four dimensions studied, and six were targeted by workers as priorities: emotional exhaustion; role conflict; ability to learn; leadership; team cohesion; and communication. Interventions developed to address the prioritised areas included: co-development workshops; training sessions aimed at enhancing workers’ control over their working environment; team connectivity through professional and social activities; staffing and workload reviews; support from a psychosocial professional; and coaching. According to workers, most improvements occurred in two targeted areas, team cohesion and communication, even in the units where these issues were not prioritised at first. Participants pinpointed some factors that facilitated the implementation of the intervention and its impact (engagement, organisational support, the bottom-up approach) and others that created constraints (staff shortages, conflicting priorities, level of commitment). Conclusions: This exploratory work offers insightful perspectives on how a bottom-up co-construction approach can serve as a lever to engage workers to improve their work experience. It may inspire other healthcare organisations, both in oncology and in other fields of activity.
- Open Access
- 7 June 2024
- Published by Wiley in Canadian Public Administration/Administration publique du Canada
- Vol. 67 (2) , 203-229
Quality Improvement Support Agencies as a systemic quality strategy: France and Québec
In a high‐quality health and social services system, policymakers encourage action at all levels of change to ensure the consistency of quality strategies. This is especially important at the systemic level, in which the other three levels of change are nested. This study aims to present an analysis of Quality Improvement Support Agencies as a systemic strategy, which has been successfully implemented in several jurisdictions. A comparative study of two critical cases in different jurisdictions was carried out: Haute autorité de santé in France (HAS) and Institut national d'excellence en santé et services sociaux (INESSS) in Québec, Canada.
- 7 June 2024
- Published by Wiley in Canadian Public Administration/Administration publique du Canada
- Vol. 67 (2) , 203-229
Open AccessQuality Improvement Support Agencies as a systemic quality strategy: France and Québec
In a high‐quality health and social services system, policymakers encourage action at all levels of change to ensure the consistency of quality strategies. This is especially important at the systemic level, in which the other three levels of change are nested. This study aims to present an analysis of Quality Improvement Support Agencies as a systemic strategy, which has been successfully implemented in several jurisdictions. A comparative study of two critical cases in different jurisdictions was carried out: Haute autorité de santé in France (HAS) and Institut national d'excellence en santé et services sociaux (INESSS) in Québec, Canada.
- Open Access
- 28 July 2023
- Published by Wiley in The International Journal of Health Planning and Management
- Vol. 38 (6) , 1706-1720
Web‐based comparative study of some national experiences of health care quality management
Since the publication of study results on adverse events to health care in OECD countries, the importance of the national quality improvement strategies has been recognised. To examine how these strategies have been shaped in different jurisdictions, we carried out this study. We conducted a web-based comparative study of international practices. We first defined seven key health care and services quality management functions. We then drew on the experience of authors to make a reasoned selection of 13 countries or states across the world. We determined the distance that separates each of these functions from a country's Ministry of Health (MoH); and examined whether these functions are concentrated in a single organisation or dispersed across several organisations. Afterwards, we correlated our results with the quality level of these countries based on the OECD's health care indicators. Overall, Netherlands, Quebec (Canada), Korea, Germany, England (UK), and the United States had at least 50% of their quality management functions controlled by self-regulated organisations. The Market Concentration Index ranged from 937 for the United States to 6800 for Russia. Graphical representation has shown us two health system models. Our results also clearly showed that countries had a better quality of care most often when they belong to model 1 of our taxonomy. These findings will help countries design and implement large-scale health care and services quality strategies for better and safer health care and services.
- 28 July 2023
- Published by Wiley in The International Journal of Health Planning and Management
- Vol. 38 (6) , 1706-1720
Open AccessWeb‐based comparative study of some national experiences of health care quality management
Since the publication of study results on adverse events to health care in OECD countries, the importance of the national quality improvement strategies has been recognised. To examine how these strategies have been shaped in different jurisdictions, we carried out this study. We conducted a web-based comparative study of international practices. We first defined seven key health care and services quality management functions. We then drew on the experience of authors to make a reasoned selection of 13 countries or states across the world. We determined the distance that separates each of these functions from a country's Ministry of Health (MoH); and examined whether these functions are concentrated in a single organisation or dispersed across several organisations. Afterwards, we correlated our results with the quality level of these countries based on the OECD's health care indicators. Overall, Netherlands, Quebec (Canada), Korea, Germany, England (UK), and the United States had at least 50% of their quality management functions controlled by self-regulated organisations. The Market Concentration Index ranged from 937 for the United States to 6800 for Russia. Graphical representation has shown us two health system models. Our results also clearly showed that countries had a better quality of care most often when they belong to model 1 of our taxonomy. These findings will help countries design and implement large-scale health care and services quality strategies for better and safer health care and services.
- Open Access
- 15 June 2023
- Published by Wiley
Comparative case study of Quality Improvement Support Agencies (QISAs) as a systemic quality strategy: France and Québec
In a high-quality health and social services system, policymakers encourage action at all levels of change to ensure the consistency of quality strategies, especially at the systemic level, in which the other three levels of change are nested and the whole system is structured. This study aims to present an analysis of Quality Improvement Support Agencies (QISAs) as a systemic strategy, which has been successfully implemented in several jurisdictions (countries and states). A comparative study of two critical cases in two different jurisdictions was carried out: Haute autorité de santé (HAS) in France and Institut national d’excellence en santé et services sociaux (INESSS) in Québec, Canada. Several sources of iteratively collected data were coded using a systematized approach. All data were processed and analyzed confidentially using the software QDA Miner 6.0.2. The results showed that HAS has a wider range of activities and INESSS has a narrower range. Their statutes of autonomy differ, with the former QISA more independent of the public power of its jurisdiction and the latter more at the service of public power. Though their products differ, these QISAs each have different effects (proximal, intermediate, and ultimate) on quality improvement in practice settings. Furthermore, it appears that they have each faced dilemmas in achieving systemic quality improvement. This study may inspire other jurisdictions to implement similar systemic quality improvement strategies or strengthen them if they have already been implemented.
- 15 June 2023
- Published by Wiley
Open AccessComparative case study of Quality Improvement Support Agencies (QISAs) as a systemic quality strategy: France and Québec
In a high-quality health and social services system, policymakers encourage action at all levels of change to ensure the consistency of quality strategies, especially at the systemic level, in which the other three levels of change are nested and the whole system is structured. This study aims to present an analysis of Quality Improvement Support Agencies (QISAs) as a systemic strategy, which has been successfully implemented in several jurisdictions (countries and states). A comparative study of two critical cases in two different jurisdictions was carried out: Haute autorité de santé (HAS) in France and Institut national d’excellence en santé et services sociaux (INESSS) in Québec, Canada. Several sources of iteratively collected data were coded using a systematized approach. All data were processed and analyzed confidentially using the software QDA Miner 6.0.2. The results showed that HAS has a wider range of activities and INESSS has a narrower range. Their statutes of autonomy differ, with the former QISA more independent of the public power of its jurisdiction and the latter more at the service of public power. Though their products differ, these QISAs each have different effects (proximal, intermediate, and ultimate) on quality improvement in practice settings. Furthermore, it appears that they have each faced dilemmas in achieving systemic quality improvement. This study may inspire other jurisdictions to implement similar systemic quality improvement strategies or strengthen them if they have already been implemented.
- Open Access
- 15 June 2023
- Published by Wiley
Contextual Factors Influencing the Effects of a Quality Improvement Support Agency (QISA): A Qualitative Study
Quality improvement has become a global priority as more countries become interested in systemic strategies, particularly that of the Quality Improvement Support Agency (QISA). This study sets out to identify and document contextual factors that facilitate or hinder the perceived effects of QISAs. A study of two critical and paradigmatic cases consisting of the QISAs HAS and INESSS was carried out through interviews, a focus group discussion, a non-participatory observation session, and the use of secondary data from in-depth documentary research. All data were recorded and processed using the QDA Miner 6.0.2 software in an inductive approach in two coding cycles and were validated by the participants. The results showed that the contextual factors at the level of the internal environment included: leadership of agency actors; dissemination and support strategy for their productions and support for their implementation; availability and nature of human, informational, and material resources; organizational culture; training of actors; and coordination, coherence, and complementarity of the various activities of an agency. At the level of the external environment, the factors included: crises; institutional collaborations and partnerships at the national and international levels; collaborations and partnerships with system actors; public policy, governance, and leadership; legal provisions; health information system and data accessibility; and funding. These results, the first to be produced on this topic, complement the literature on QISAs and may thus inspire other jurisdictions in developed and developing countries to implement more efficient, sustainable, and self-potentiating quality improvement strategies.
- 15 June 2023
- Published by Wiley
Open AccessContextual Factors Influencing the Effects of a Quality Improvement Support Agency (QISA): A Qualitative Study
Quality improvement has become a global priority as more countries become interested in systemic strategies, particularly that of the Quality Improvement Support Agency (QISA). This study sets out to identify and document contextual factors that facilitate or hinder the perceived effects of QISAs. A study of two critical and paradigmatic cases consisting of the QISAs HAS and INESSS was carried out through interviews, a focus group discussion, a non-participatory observation session, and the use of secondary data from in-depth documentary research. All data were recorded and processed using the QDA Miner 6.0.2 software in an inductive approach in two coding cycles and were validated by the participants. The results showed that the contextual factors at the level of the internal environment included: leadership of agency actors; dissemination and support strategy for their productions and support for their implementation; availability and nature of human, informational, and material resources; organizational culture; training of actors; and coordination, coherence, and complementarity of the various activities of an agency. At the level of the external environment, the factors included: crises; institutional collaborations and partnerships at the national and international levels; collaborations and partnerships with system actors; public policy, governance, and leadership; legal provisions; health information system and data accessibility; and funding. These results, the first to be produced on this topic, complement the literature on QISAs and may thus inspire other jurisdictions in developed and developing countries to implement more efficient, sustainable, and self-potentiating quality improvement strategies.
- Open Access
- 5 December 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-12
Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Background: Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries.Methods: As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0.Results: In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4–55.9). In 16 pooled studies that included 1782 people with mental disorders and 1776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7–3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7–3.4).Conclusion: Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied.
- 5 December 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-12
Open AccessAssociations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Background: Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries.Methods: As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0.Results: In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4–55.9). In 16 pooled studies that included 1782 people with mental disorders and 1776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7–3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7–3.4).Conclusion: Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied.
- Open Access
- 13 November 2019
- Published by Springer Nature in Research Square
Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries. As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0. In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4). Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied. Keywords: Meta-analysis, association, co-morbidities, mental disorders, neurotropic parasitic diseases.
- 13 November 2019
- Published by Springer Nature in Research Square
Open AccessAssociations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries. As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0. In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4). Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied. Keywords: Meta-analysis, association, co-morbidities, mental disorders, neurotropic parasitic diseases.
- Open Access
- 11 November 2019
- Published by Springer Nature in Research Square
Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries. As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0. In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4). Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied. Keywords: Meta-analysis, association, co-morbidities, mental disorders, neurotropic parasitic diseases.
- 11 November 2019
- Published by Springer Nature in Research Square
Open AccessAssociations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries. As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0. In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4). Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied. Keywords: Meta-analysis, association, co-morbidities, mental disorders, neurotropic parasitic diseases.
- Open Access
- 11 November 2019
- Published by Springer Nature in Research Square
Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries. As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0. In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4). Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied. Keywords: Meta-analysis, association, co-morbidities, mental disorders, neurotropic parasitic diseases.
- 11 November 2019
- Published by Springer Nature in Research Square
Open AccessAssociations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries. As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0. In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4). Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied. Keywords: Meta-analysis, association, co-morbidities, mental disorders, neurotropic parasitic diseases.
- Open Access
- 18 October 2019
- Published by Springer Nature in Research Square
Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries.
Background Although they are declining worlwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries.Methods As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0..Results In total, 18 studies studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4).Conclusion Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied.
- 18 October 2019
- Published by Springer Nature in Research Square
Open AccessAssociations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries.
Background Although they are declining worlwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries.Methods As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0..Results In total, 18 studies studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4 – 55.9). In 16 pooled studies that included 1,782 people with mental disorders and 1,776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7 – 3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7 – 3.4).Conclusion Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied.